Breakthrough therapy-designated oncology drugs: are they rightfully criticized?
| Autor: | Mulder, Jorn, Pasmooij, Anna M.G., Stoyanova-Beninska, Violeta V., Schellens, Jan H.M. |
|---|---|
| Zdroj: | In Drug Discovery Today September 2020 25(9):1580-1584 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect